title: Response #2 to Immediate Intraocular Pressure Tendency Following Intravitreal Delivery of Dexamethasone Implant; Alagöz et al. J. Ocul. Pharmacol. Ther. 32:44-49, 2016.
authors.affiliation: Department of Ophthalmology, Araba University Hospital , Vitoria-Gasteiz, Spain .
authors.forename: Gonzaga
authors.initials: G
authors.lastname: Garay-Aramburu
authors.affiliation: Department of Ophthalmology, Araba University Hospital , Vitoria-Gasteiz, Spain .
authors.forename: Angela
authors.initials: A
authors.lastname: Gomez-Moreno
mesh_terms: D003907:Dexamethasone / Q000008:administration & dosage* / Q000009:adverse effects; D004343:Drug Implants / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology; D058449:Intravitreal Injections / Q000009:adverse effects; D008269:Macular Edema / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011446:Prospective Studies
chemical_list: D004343:Drug Implants; D003907:Dexamethasone